A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
TruBridge, Inc.
TBRG
$389M
Mkt Cap
TruBridge, Inc. (TBRG) has a current P/E ratio of 53.4, compared to its historical median P/E of 24.6. The stock is currently considered Expensive based on its historical valuation range.
TruBridge, Inc. (TBRG) has a 5-year average return on invested capital (ROIC) of 1.4%. This is below average and may indicate limited pricing power.
TruBridge, Inc. (TBRG) has a market capitalization of $297M. It is classified as a small-cap stock.
TruBridge, Inc. (TBRG) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 0.14%.
Based on historical P/E analysis, TruBridge, Inc. (TBRG) appears expensive. The current P/E of 53.4 is 117% above its historical median of 24.6. The estimated fair value CAGR (P/E method) is -20.7%.
TruBridge, Inc. (TBRG) operates in the Services-Computer Programming Services industry, within the Technology sector.
TruBridge, Inc. (TBRG) reported annual revenue of $343 million in its most recent fiscal year, based on SEC EDGAR filings.
Founded in 1979, TruBridge, Inc. (“TruBridge” or the “Company”) is a leading provider of healthcare solutions and services for community hospitals, their clinics and other healthcare systems. Previously named Computer Programs and Systems, Inc., the Company changed its name to TruBridge, Inc. on March 4, 2024 in a Company-wide rebranding and legal entity consolidation. TruBridge is a trusted partner to more than 1,500 healthcare organizations with a broad range of technology-first solutions that address the unique needs and challenges of diverse communities, promoting equitable access to quality care and fostering positive outcomes. TruBridge has over four decades of experience in connecting providers, patients and communities with innovative data-driven solutions that create real value by supporting both the financial and clinical side of healthcare delivery.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 350M | 343M | 336M | 327M | 281M | 264M |
| Net Income | 5.6M | -20M | -48M | 16M | 18M | 14M |
| EPS | $0.37 | $-1.38 | $-3.34 | $1.08 | $1.26 | $0.98 |
| Free Cash Flow | 37M | 30M | 713K | 32M | 47M | 46M |
| ROIC | 4.1% | 1.9% | -12.8% | 5.5% | 6.4% | 6.0% |
| Gross Margin | - | 50.8% | 47.7% | 49.0% | 50.2% | 51.5% |
| Debt/Equity | 0.91 | 1.02 | 1.08 | 0.60 | 0.45 | 0.38 |
| Dividends/Share | $0.00 | - | - | - | - | $0.30 |
| Operating Income | 25M | 6.6M | -46M | 23M | 25M | 21M |
| Operating Margin | 7.2% | 1.9% | -13.7% | 7.0% | 8.8% | 8.0% |
| ROE | 3.1% | -11.6% | -26.3% | 6.8% | 8.3% | 7.1% |
| Shares Outstanding | 15M | 15M | 15M | 15M | 15M | 15M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 201M | 205M | 182M | 267M | 277M | 280M | 275M | 264M | 281M | 327M | 336M | 343M | 350M |
| Gross Margin | 46.7% | 45.9% | 51.9% | 51.4% | 53.2% | 53.4% | 52.5% | 51.5% | 50.2% | 49.0% | 47.7% | 50.8% | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT | 50M | 50M | 25M | 14M | -4.8M | 25M | 25M | 21M | 25M | 23M | -46M | 6.6M | 25M |
| Op. Margin | 25.0% | 24.2% | 13.8% | 5.4% | -1.7% | 8.9% | 9.0% | 8.0% | 8.8% | 7.0% | -13.7% | 1.9% | 7.2% |
| Net Income | 33M | 33M | 18M | 3.9M | -17M | 18M | 20M | 14M | 18M | 16M | -48M | -20M | 5.6M |
| Net Margin | 16.3% | 16.1% | 10.1% | 1.5% | -6.3% | 6.3% | 7.5% | 5.4% | 6.6% | 4.9% | -14.4% | -6.0% | 1.6% |
| Non-Recurring | 0 | 0 | 0 | 0 | 28M | 0 | 0 | 0 | 0 | 0 | 36M | 0 | 0 |
| Returns on Capital | |||||||||||||
| ROIC | 69.5% | 70.9% | 45.6% | 2.3% | -1.7% | 8.5% | 7.5% | 6.0% | 6.4% | 5.5% | -12.8% | 1.9% | 4.1% |
| ROE | 47.4% | 40.8% | 24.3% | 2.5% | -12.8% | 11.0% | 11.1% | 7.1% | 8.3% | 6.8% | -26.3% | -11.6% | 3.1% |
| ROA | 35.4% | 33.1% | 19.8% | 1.2% | -5.5% | 5.4% | 6.0% | 4.4% | 4.8% | 3.7% | -11.2% | -4.9% | 1.4% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | 29M | 39M | 31M | 2.1M | 24M | 24M | 44M | 49M | 48M | 32M | 1.1M | 32M | 38M |
| Free Cash Flow | 25M | 37M | 30M | 2.1M | 23M | 23M | 42M | 46M | 47M | 32M | 713K | 30M | 37M |
| Owner Earnings | 24M | 31M | 22M | -6.3M | 14M | 12M | 32M | 40M | 40M | 25M | -4.2M | 25M | 32M |
| CapEx | 3.6M | 1.5M | 448K | 39K | 726K | 978K | 1.8M | 3.3M | 920K | 270K | 346K | 1.6M | 1.2M |
| Maint. CapEx | 3.4M | 3.7M | 3.2M | 3.1M | 2.5M | 1.8M | 1.4M | 1.8M | 2.2M | 2.4M | 1.9M | 1.3M | 1.3M |
| Growth CapEx | 201K | 0 | 0 | 0 | 0 | 0 | 353K | 1.5M | 0 | 0 | 0 | 297K | 0 |
| D&A | 3.4M | 3.7M | 3.2M | 3.1M | 2.5M | 1.8M | 1.4M | 1.8M | 2.2M | 2.4M | 1.9M | 1.3M | 1.3M |
| CapEx/OCF | 12.5% | 3.8% | 1.5% | 1.9% | 3.1% | 4.1% | 4.0% | 6.8% | 1.9% | 0.8% | 32.7% | 5.1% | 3.1% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 23M | 26M | 29M | 25M | 12M | 5.6M | 5.7M | 4.3M | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | 4.7% | 4.4% | 5.9% | 5.2% | 3.1% | 1.4% | 1.5% | 1.2% | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.3M | 1.3M | 12M | 2.6M | 404K | 404K |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.3% | 0.3% | 3.1% | 1.6% | 0.1% | 0.1% |
| Stock-Based Comp | 1.7M | 4.2M | 5.4M | 5.4M | 7.2M | 9.7M | 9.8M | 7.0M | 5.5M | 5.2M | 3.3M | 5.5M | 5.5M |
| Debt Repayment | 0 | 0 | 0 | 5.2M | 6.3M | 13M | 14M | 4.1M | 3.8M | 3.6M | 3.5M | 7.5M | 7.5M |
| Balance Sheet | |||||||||||||
| Net Debt | N/A | N/A | -36M | 151M | 142M | 125M | 101M | 64M | 88M | 133M | 195M | 159M | 144M |
| Cash & Equiv. | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 20M |
| Long-Term Debt | N/A | N/A | 0 | 147M | 137M | 125M | 99M | 73M | 95M | 136M | 195M | 169M | 169M |
| Debt/Equity | 0.34 | 0.23 | 0.00 | 0.97 | 1.05 | 0.82 | 0.59 | 0.38 | 0.45 | 0.60 | 1.08 | 1.02 | 0.91 |
| Interest Coverage | N/A | N/A | N/A | 2.2 | -0.6 | 3.3 | 3.7 | 5.9 | 7.8 | 3.6 | -3.7 | 0.4 | 0.4 |
| Equity | 69M | 81M | 75M | 158M | 136M | 160M | 184M | 200M | 223M | 232M | 184M | 169M | 180M |
| Total Assets | 93M | 99M | 93M | 339M | 318M | 328M | 340M | 326M | 383M | 431M | 432M | 394M | 399M |
| Total Liabilities | 23M | 19M | 17M | 181M | 182M | 168M | 155M | 126M | 161M | 199M | 248M | 226M | 219M |
| Intangibles | N/A | N/A | N/A | 168M | 140M | 140M | 150M | 150M | 178M | 198M | 172M | 173M | 173M |
| Retained Earnings | 34M | 42M | 31M | 10M | -19M | -5.0M | 9.7M | 20M | 38M | 54M | 5.5M | -15M | -15M |
| Working Capital | 51M | 63M | 57M | 14M | 17M | 31M | 25M | 30M | 23M | 30M | 61M | 37M | 37M |
| Current Assets | 73M | 82M | 75M | 45M | 58M | 70M | 67M | 67M | 69M | 75M | 109M | 90M | 90M |
| Current Liabilities | 21M | 18M | 17M | 31M | 41M | 39M | 42M | 37M | 46M | 44M | 48M | 53M | 53M |
| Per Share Data | |||||||||||||
| EPS | 2.95 | 2.94 | 1.62 | 0.29 | -1.27 | 1.26 | 1.43 | 0.98 | 1.26 | 1.08 | -3.34 | -1.38 | 0.37 |
| Owner EPS | 2.15 | 2.78 | 1.97 | -0.47 | 1.02 | 0.89 | 2.26 | 2.78 | 2.74 | 1.69 | -0.29 | 1.71 | 2.10 |
| Book Value | 6.22 | 7.21 | 6.66 | 11.65 | 9.92 | 11.42 | 12.88 | 13.76 | 15.22 | 15.77 | 12.69 | 11.39 | 12.02 |
| Cash Flow/Share | 2.62 | 3.48 | 2.73 | 0.16 | 1.72 | 1.71 | 3.05 | 3.38 | 3.26 | 2.20 | 0.07 | 2.17 | 0.46 |
| Dividends/Share | 2.04 | 2.28 | 2.56 | 1.85 | 0.85 | 0.40 | 0.40 | 0.30 | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 11.1M | 11.2M | 11.3M | 13.6M | 13.7M | 14.0M | 14.3M | 14.5M | 14.6M | 14.7M | 14.5M | 14.8M | 15.0M |
| Valuation | |||||||||||||
| P/E Ratio | 17.2 | 17.6 | 27.5 | 75.9 | N/A | 19.6 | 18.7 | 28.3 | 23.4 | 24.6 | N/A | N/A | 53.4 |
| P/FCF | 22.1 | 15.5 | 16.6 | 144.5 | 16.9 | 15.0 | 9.1 | 8.8 | 9.2 | 12.1 | 231.2 | 9.3 | 8.0 |
| EV/EBIT | N/A | N/A | 18.7 | 31.2 | N/A | 18.9 | 19.6 | 22.2 | 21.0 | 22.9 | N/A | 66.9 | 17.6 |
| Price/Book | 8.1 | 7.2 | 6.7 | 1.9 | 2.8 | 2.2 | 2.1 | 2.0 | 1.9 | 1.7 | 0.9 | 1.7 | 1.6 |
| Price/Sales | 2.4 | 2.8 | 2.7 | 1.8 | 1.4 | 1.4 | 1.4 | 1.4 | 1.7 | 1.4 | 1.0 | 0.5 | 0.8 |
| FCF Yield | 4.5% | 6.5% | 6.0% | 0.7% | 5.9% | 6.7% | 11.0% | 11.4% | 10.9% | 8.2% | 0.4% | 10.7% | 12.5% |
| Market Cap | 562M | 580M | 505M | 298M | 388M | 345M | 382M | 403M | 431M | 390M | 165M | 285M | 297M |
| Avg. Price | 43.74 | 51.96 | 43.58 | 35.27 | 27.45 | 28.22 | 25.94 | 25.55 | 32.24 | 30.59 | 22.12 | 11.43 | 19.77 |
| Year-End Price | 50.63 | 51.82 | 44.58 | 22.01 | 28.28 | 24.65 | 26.69 | 27.74 | 29.48 | 26.54 | 11.37 | 19.22 | 19.77 |
TruBridge, Inc. passes 0 of 9 quality checks, indicating weak fundamentals.
TruBridge, Inc. trades at 53.4x trailing earnings, compared to its 15-year median P/E of 24.6x, suggesting it is currently Expensive relative to its historical range. On a free-cash-flow basis, the stock trades at 8.0x vs a median of 10.7x. The company's 5-year average ROIC is 1.4% with a gross margin of 49.8%. Total shareholder yield (buybacks) is 0.1%. At current prices, the estimated annualized return to fair value is -10.5%.
TruBridge, Inc. (TBRG) has a net profit margin of -6.0%. The company is currently unprofitable.
TruBridge, Inc. (TBRG) generated $30 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
TruBridge, Inc. (TBRG) has a debt-to-equity ratio of 1.02. This indicates moderate leverage.
TruBridge, Inc. (TBRG) reported earnings per share (EPS) of $-1.38 in its most recent fiscal year.
TruBridge, Inc. (TBRG) has a return on equity (ROE) of -11.6%. A negative ROE may indicate losses or negative equity.
TruBridge, Inc. (TBRG) has a 5-year average gross margin of 49.8%. This indicates decent pricing power.
The Ledger Terminal provides 12 years of financial data for TruBridge, Inc. (TBRG), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
TruBridge, Inc. (TBRG) has a book value per share of $11.39, based on its most recent annual SEC filing.